Peel Hunt Reaffirms “Hold” Rating for Victrex (LON:VCT)
Peel Hunt reaffirmed their hold rating on shares of Victrex (LON:VCT) in a research report report published on Monday morning, ThisIsMoney.Co.Uk reports.
Other equities research analysts have also recently issued reports about the company. UBS Group upped their target price on LyondellBasell Industries from $86.00 to $89.00 and gave the stock a neutral rating in a report on Thursday, July 11th. Numis Securities reiterated a buy rating on shares of BT Group – CLASS A in a report on Monday, May 13th. Credit Suisse Group reiterated an outperform rating on shares of in a report on Wednesday, June 5th. JPMorgan Chase & Co. upped their price objective on from GBX 2,300 ($30.05) to GBX 2,900 ($37.89) and gave the stock a neutral rating in a research note on Friday, July 5th. Finally, Berenberg Bank decreased their price objective on BT Group from GBX 260 ($3.40) to GBX 240 ($3.14) and set a hold rating for the company in a research note on Tuesday, May 21st. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. Victrex presently has an average rating of Hold and an average target price of GBX 2,300.45 ($30.06).
Shares of VCT stock opened at GBX 1,944 ($25.40) on Monday. Victrex has a twelve month low of GBX 1,943 ($25.39) and a twelve month high of GBX 3,434 ($44.87). The stock has a market cap of $1.68 billion and a PE ratio of 16.90. The stock has a fifty day moving average price of GBX 2,078.64.
In other Victrex news, insider Jane Toogood purchased 500 shares of the firm’s stock in a transaction on Friday, May 31st. The stock was bought at an average cost of GBX 1,972 ($25.77) per share, for a total transaction of £9,860 ($12,883.84). Also, insider Jakob Sigurdsson purchased 3,000 shares of the firm’s stock in a transaction on Tuesday, May 14th. The stock was acquired at an average price of GBX 2,092 ($27.34) per share, with a total value of £62,760 ($82,007.06). Insiders have purchased a total of 4,228 shares of company stock valued at $8,197,928 over the last 90 days.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
See Also: How Do Mutual Funds Work?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.